1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Metabolic reprogramming in diabetes and other endocrine and metabolic disorders : exploring the Warburg effect, ketones, and SGLT2 inhibitors
(2025) In Reviews in Endocrine and Metabolic Disorders
- Contribution to journal › Article
- 2020
-
Mark
Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
- Contribution to journal › Scientific review
-
Mark
Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
- Contribution to journal › Scientific review
- 2004
-
Mark
Candidate genes for type 2 diabetes.
- Contribution to journal › Scientific review
-
Mark
Molecular defects in insulin secretion in type-2 diabetes
- Contribution to journal › Article